Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

HPV vaccine study tests if personal stories convince parents better than facts alone

NCT ID NCT06587243

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 26 times

Summary

This study compares three ways to encourage HPV vaccination: showing parents an informational video, a personal story from someone with HPV, or both together. Researchers will track which group has the most parents get their 11-17 year old children vaccinated. The goal is to find the most effective communication strategy to increase HPV vaccine uptake.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VACCINATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ipsos

    RECRUITING

    New York, New York, 10016, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Informational animation video and personal narrative video

What this could lead to

If successful, this approach could provide a simple, scalable way to increase HPV vaccination rates among adolescents.

What could go wrong

This is a behavioral study, not a medical treatment, so results may vary by population. The effect may be small or not last long-term.

Conditions

The condition(s) this trial relates to.

Communication Narration human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.